Nerreter, Thomas
Universitätsklinikum Würzburg
3 papers on CoChatORCID 0000-0002-0493-1369
Most cited papers
- Verified
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Luu, M., Riester, Z., Baldrich, A., Reichardt, N., Yuille, S., Busetti, A., Klein, M., Wempe, A., Leister, H., Raifer, H., et al. (2021) · Nature Communications
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 771
- Verified
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Mestermann, K., Giavridis, T., Weber, J., Rydzek, J., Frenz, S., Nerreter, T., Mades, A., Sadelain, M., Einsele, H., & Hudecek, M. (2019) · Science Translational Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 531
- Verified
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
Wallstabe, L., Göttlich, C., Nelke, L. C., Kühnemundt, J., Schwarz, T., Nerreter, T., Einsele, H., Walles, H., Dandekar, G., Nietzer, S. L., et al. (2019) · JCI Insight
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 193
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free